Agencies issue update on ethylene oxide risk from commercial sterilizers

Aug 03, 2022 - 04:01 PM
fda-update-breast-implant

The Environmental Protection Agency today released a list of commercial medical device sterilizing facilities where lifetime risk from ethylene oxide emissions are highest to people who live nearby. In addition, the Food and Drug Administration released a statement highlighting how the agency is working to reduce ethylene oxide use and support innovation in medical device sterilization, while underscoring its concern about potential shortages that could result from disruptions in sterilizer operations. About half of medical devices are sterilized using ethylene oxide. The EPA will host an Aug. 10 webinar to update and hear from stakeholders as it prepares to propose an air pollution regulation next year to address ethylene oxide emissions. Register here to attend.

Related News Articles

Headline
Baxter recalls certain IV bags due to possible particulate matter 
Baxter is voluntarily recalling a specific lot of intravenous solution due to a report of particulate matter in the solution identified as cardboard, according…
Headline
FDA issues alert for certain Medline convenience kits 
The Food and Drug Administration has issued an early alert for specific lots of BD ChloraPrep Applicators by Medline because of a potential breach of sterility…
Headline
FDA recalls certain first aid kits with TRUE METRIX blood glucose devices 
The Food and Drug Administration has identified a Class I recall of North American Rescue first aid kits containing TRUE METRIX Blood Glucose Monitoring…
Headline
Highest FDA recall issued for certain catheters, heart pump controllers
The Food and Drug Administration has identified a Class I recall of reprocessed electrophysiology and ultrasound catheters by Medline Industries due…
Headline
FDA says shortage of breast biopsy needles expected to last until 2027 
The Food and Drug Administration June 16 announced that a nationwide shortage of stereotactic breast biopsy needles is expected to last through the end of…
Headline
FDA issues alert for Abiomed heart pump controllers 
The Food and Drug Administration has issued an early alert for all heart pump controllers by Abiomed, which sent a correction notice to all customers with…